References
Wu S.Y., Chopra I.J., Solomon D.H., Bennet L.R. Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin) an agent for oral cholecystography. J. Clin. Endocrinol. Metab. 46: 691, 1978.
Wu S.Y., Chopra I.J., Solomon D.H., Johnson D.E. The effect of repeated administration of ipodate (Oragrafin) in hyperthyroidism. J. Clin. Endocrinol. Metab. 47: 1358, 1978.
Wu S.Y. Some newer agents in the treatment of hyperthyroidism. In: Brown J. (Moderator), Autoimmune thyroid diseases -Graves’ and Hashimoto’s. Ann. Intern. Med. 88: 389, 1978.
Emerson C.H., Anderson A.J., Howard W.J., Utiger R.D. Serum thyroxine and triiodothyronine concentrationsduring iodine treatment of hyperthyroidism. J. Clin. Endocrinol. Metab. 40: 33, 1975.
Burgi H., Wimpfheimer C., Burger A., Zaunbauer W., Rosier H, Lemarchand-Béraud T. Changes.of circulating thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents. J. Clin. Endocrinol. Metab. 43: 1203, 1976.
Mirouze J., Jaffiol C., Nguyen Due Hai, Pastorello R., Baldet L. Analyse de l’inhibition thyroidienne après explorations ra-diologiques par produits de contraste iodés. Ann. Endocrinol. (Paris) 28: 807, 1967.
Lievendhal K. Iodochloroxyquinoline and the thyroid gland. Acta Endocrinol (Kbh.) (Suppl.) 59: 133, 1968.
Delzant G., Massin J.P. Problèmes thérapeutiques posés par les hyperthyroidies avec surcharge iodée. In: Decourt J., Gilbert-Dreyfus (Eds.), Actualités Endo- crinologiques. L’Expansion, Paris, 1970, p. 149.
Costa A., Brambati-Testori O., Cenderelli C., Giribone G., Migliardi M. Iodine content of human tissues after administration of iodine containing drugs or contrast media. J. Endocrinol. Invest. 1: 221, 1978.
Schneider C., Stephan G., Suwelack M. Uber das Hyperthyreoserisiko bei iatrogener Jodzufuhr. Dtsch. Med. Wochenschr. 94: 2631, 1969.
References
Wu S.Y., Chopra I.J., Solomon D.H., Bennett L.R. Changes in circulating iodothyronines in euthyroid and hyperthyroid subjects given ipodate (Oragrafin), an agent for oral cholecystography. J. Clin. Endocrinol. Metab. 46: 691, 1978.
Wu S.Y., Chopra I.J., Solomon D.H., Johnson D.E. The effect of repeated administration of ipodate (Oragrafin) in hyperthyroidism. J. Clin. Endocrinol. Metab. 47: 1358, 1978.
Green W.L, Bellamy G. Role of organic anion transport systems in uptake and metabolism of thyroid hormones by rat liver slices. Proceedings of the 53nd Meeting of the American Thyroid Association, Cleveland, Ohio, September 7–10, 1977, p. T–16. (Abstract).
Felicetta J.V., Nelp W.B., Green W.L. Inhibition of hepatic binding of thyroid hormones by a cholecystographic agent, sodium tyropanoate. Proceedings of 61 st Annual Meeting of the Endocrine Society, Anaheim, California, June 13–15, 1 979, p. 237, Abstract 658.
DeGroot L.J. Personal communication.
Vagenakis A.G., Pang C.A., Burger A., Braverman L.E., Ingbar S.H. Iodide-induced thyrotoxicosis in Boston. N. Engl. J. Med. 287: 523, 1972.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Costa, A., Chopra, I.J., Solomon, D.H. et al. The use of X-ray contrast media in the treatment of hyperthyroidism. J Endocrinol Invest 2, 461–462 (1979). https://doi.org/10.1007/BF03349350
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349350